Amoxil and Fenofibrate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Amoxil (amoxicillin) and Fenofibrate (fenofibrate). Common drug interactions include diabetic neuropathy among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Amoxil and Fenofibrate. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Amoxil?

Amoxil has active ingredients of amoxicillin. It is often used in infection. eHealthMe is studying from 3,641 Amoxil users. Check the latest studies of Amoxil.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,456 Fenofibrate users. Check the latest studies of Fenofibrate.



On Jul, 04, 2026

11 people who take Amoxil and Fenofibrate together, and have interactions are studied.

Amoxil and Fenofibrate drug interactions.

What are the common drug interactions of Amoxil and Fenofibrate, by gender? *:

female:

  1. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  2. Glomerulonephritis rapidly progressive (a syndrome of the kidney that is characterized by a rapid loss of renal function)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Renal failure (kidney dysfunction)
  5. Renal injury (kidney injury)
  6. Bronchial hyperreactivity
  7. Depression
  8. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
  9. Erythema (redness of the skin)
  10. Fibromyalgia (a long-term condition which causes pain all over the body)

male:

  1. Asthenia (weakness)
  2. Body temperature increased
  3. Lung disorder (lung disease)
  4. Adenocarcinoma pancreas (cancer of pancreas)
  5. Hospitalisation
  6. Osteomyelitis (infection of bone)
  7. Pancreatitis acute (sudden inflammation of pancreas)

What are the common drug interactions of Amoxil and Fenofibrate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  2. Diabetic nephropathy (diabetic kidney disease)
  3. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  4. Glomerulonephritis rapidly progressive (a syndrome of the kidney that is characterized by a rapid loss of renal function)
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Renal failure (kidney dysfunction)
  7. Renal injury (kidney injury)
  8. Erythema (redness of the skin)
  9. Grip strength decreased
  10. Hypoaesthesia (reduced sense of touch or sensation)

50-59:

  1. Asthenia (weakness)
  2. Body temperature increased
  3. Lung disorder (lung disease)
  4. Chronic kidney disease
  5. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

60+:

  1. Adenocarcinoma pancreas (cancer of pancreas)
  2. Hospitalisation
  3. Osteomyelitis (infection of bone)
  4. Pancreatitis acute (sudden inflammation of pancreas)

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 4 people, 36.36%
  2. Diabetes: 3 people, 27.27%
  3. Weight Loss: 2 people, 18.18%
  4. Depression: 2 people, 18.18%
  5. Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 18.18%
  6. Cryptococcosis (potentially fatal fungal disease): 2 people, 18.18%
  7. High Blood Pressure: 2 people, 18.18%
  8. Hypokalemia (low potassium): 2 people, 18.18%
  9. Inflammation: 2 people, 18.18%
  10. Type 2 Diabetes: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Amoxil and Fenofibrate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Amoxil and Fenofibrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Amoxil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Fenofibrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amoxil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fenofibrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on amoxicillin and fenofibrate (the active ingredients of Amoxil and Fenofibrate, respectively), and Amoxil and Fenofibrate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: